Markets:

Overview

News

Currencies

International

Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

2.690 -0.310 (-10.33%)

Streaming Delayed Price Updated: 9:47 AM EDT, May 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Evotec launches PanOmics Data Analysis Platform PanHunter at Bio-IT World

October 18, 2022

Via ACCESSWIRE

Evotec and TIAP Expand LAB150 BRIDGE Partnership to Include Amgen

October 17, 2022

Via ACCESSWIRE

TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen

October 17, 2022

From Toronto Innovation Acceleration Partners

Via Business Wire

Adapsyn Bioscience Inks Collaboration Pact With Evotec ↗

September 21, 2022

Via Benzinga

Ford, Evotec And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

September 20, 2022

U.S. stock futures traded lower this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session.

Via Benzinga

Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies Program

September 20, 2022

Via ACCESSWIRE

Evotec Initiates Ground-Breaking for New Biologics Facility J.POD(R) Toulouse, France (EU)

September 16, 2022

Via ACCESSWIRE

Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany

August 25, 2022

Via ACCESSWIRE

Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday ↗

August 23, 2022

GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday.

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

Evotec SE Reports Results for the First Half-year 2022 and Provides Corporate Updates

August 11, 2022

Via ACCESSWIRE

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session ↗

August 10, 2022

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

Via Benzinga

WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday ↗

August 10, 2022

OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.

Via Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022 ↗

August 10, 2022

Via Benzinga

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 10, 2022

Gainers

Via Benzinga

Evotec, Alpine Expand Pact For Commercial Process Development Of Autoimmune Disease Candidate ↗

August 10, 2022

Via Benzinga

Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket ↗

August 10, 2022

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.

Via Benzinga

Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303

August 10, 2022

Via ACCESSWIRE

Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303

August 10, 2022

From Alpine Immune Sciences Inc.

Via Business Wire

Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders ↗

August 08, 2022

An estimated 200 million Americans — more than 60% of the population — suffer from at least one neurological disorder. That includes dementia, strokes, migraines and other diseases or infections that...

Via Benzinga

Evotec SE Reports First Half-year 2022 Results on 11 August 2022

August 04, 2022

Via ACCESSWIRE

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate ↗

July 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

This Biotech Company Says That It's Looking To Deliver A Breakthrough In Psychiatric Medicine — What's The Scoop? ↗

June 27, 2022

Pasithea Therapeutics Corp. (NASDAQ: KTTA) is a biotech company with a goal of investigating novel drug treatments to provide more effective relief to the estimated 792 million people around the world...

Via Benzinga

Evotec SE Reports Results of Annual General Meeting 2022

June 22, 2022

HAMBURG, GERMANY / ACCESSWIRE / June 22, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that its shareholders approved all proposals the...

From Evotec SE

Via AccessWire

Topics Artificial Intelligence

Exscientia -Evotec Cancer Therapy Shows Encouraging Action In Healthy Volunteers ↗

June 14, 2022

Via Benzinga

Evotec Enters a Drug Discovery Collaboration with Janssen

June 14, 2022

HAMBURG, GERMANY / ACCESSWIRE / June 14, 2022 / Evotec SE (FRA:EVT)(MDAX/TecDAX)(ISIN:DE0005664809)(NASDAQ:EVO) announced today that the Company has entered a drug discovery collaboration with Janssen...

From Evotec SE

Via AccessWire

Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand

May 30, 2022

CELLS PLATFORM INTEGRATES INNOVATIVE OFF-THE-SHELF IPSC CELL THERAPY DISCOVERY WITH DEVELOPMENT AND MANUFACTURING

From Evotec AE

Via AccessWire

The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate ↗

May 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology

May 19, 2022

HAMBURG, GERMANY and BARCELONA, SPAIN / ACCESSWIRE / May 19, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) and Almirall S.A. (ALM), a global...

From Evotec AG

Via AccessWire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.